Packaging & Labelling
CEVA Logistics opens Singapore cold station as part of global healthcare logistics solution
CEVA Logistics opened its temperature-controlled airfreight station today adjacent to Singapore’s Changi International Airport, positioning Singapore as a strategic healthcare logistics hub for the...
News
AirBridgeCargo Airlines completes a series of charter flights with packaging machines for COVID-19 associated items
AirBridgeCargo Airlines, part of Volga-Dnepr Group and one of the leaders in air transportations for the healthcare sector, has accomplished five Boeing 747F charter...
News
Easyfairs partners with MIND Exhibitions to launch Connect in Pharma
Easyfairs continues to grow in packaging sector in Europe. The events organizer is extending its international network with the creation of a new trade...
Drug Research
Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential
Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, announced a four-year collaboration with the Bill & Melinda...
Drug Research
EnGeneIC develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and stimulates a broad anti-viral response
EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to stimulate...
Drug Research
NeuExcell and Spark partner to develop gene therapy for Huntingtons Disease
NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group announced a gene therapy collaboration aimed at developing a safe and effective treatment...
Drug Research
Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Government of Japan
Takeda Pharmaceutical Company Limited announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read